NCT00130832 Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00130806 An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065) Status TERMINATED Phase PHASE3
NCT00130793 A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00130182 A Study in Pediatric Patients With Cystic Fibrosis Lung Disease Status COMPLETED Phase PHASE2
NCT00129402 Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH (Study P02579) Status COMPLETED Phase PHASE3
NCT00128115 Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032) Status TERMINATED Phase PHASE2
NCT00128102 Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (MK-0683-014) Status COMPLETED Phase PHASE3
NCT00127192 A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044) Status COMPLETED Phase PHASE2
NCT00127153 A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013) Status COMPLETED Phase PHASE3
NCT00127140 A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Malignant Lymphoma (0683-030) Status COMPLETED Phase PHASE1
NCT00127127 A Study of Vorinostat in Patients With Solid Tumors (MK-0683-029) Status COMPLETED Phase PHASE1
NCT00127101 An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED) Status TERMINATED Phase PHASE1
NCT00126451 A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED) Status TERMINATED Phase PHASE2
NCT00126308 Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy Status TERMINATED Phase PHASE4
NCT00125060 Transesophageal Magnetic Resonance Imaging (MRI) in Conjunction With Lipid Lowering Measures Status COMPLETED Phase NA
NCT00124735 A Study to Determine the Dose Requirements of Rocuronium Bromide (Zemuron®) in Pediatric and Adolescent Subjects (21048)(COMPLETED)(P05797) Status COMPLETED Phase PHASE3
NCT00124722 A Study to Compare Different Intubating Doses of Zemuron in Pediatric and Adolescent Subjects Under General Anesthesia Status COMPLETED Phase PHASE3
NCT00124072 Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine Status COMPLETED Phase PHASE3